These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9734883)

  • 1. Adjuvant portal-vein infusion of fluorouracil and heparin in colorectal cancer: a randomised trial. European Organisation for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group, the Gruppo Interdisciplinare Valutazione Interventi in Oncologia, and the Japanese Foundation for Cancer Research.
    Rougier P; Sahmoud T; Nitti D; Curran D; Doci R; De Waele B; Nakajima T; Rauschecker H; Labianca R; Pector JC; Marsoni S; Apolone G; Lasser P; Couvreur ML; Wils J
    Lancet; 1998 Jun; 351(9117):1677-81. PubMed ID: 9734883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Final results of a phase III clinical trial on adjuvant intraportal infusion with heparin and 5-fluorouracil (5-FU) in resectable colon cancer (EORTC GITCCG 1983-1987). European Organization for Research and Treatment of Cancer. Gastrointestinal Tract Cancer Cooperative Group.
    Nitti D; Wils J; Sahmoud T; Curran D; Couvreur ML; Lise M; Rauschecker H; dos Santos JG; Stremmel W; Roelofsen F
    Eur J Cancer; 1997 Jul; 33(8):1209-15. PubMed ID: 9301444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized clinical trial of adjuvant radiotherapy and 5-fluorouracil infusion in colorectal cancer (AXIS).
    James RD; Donaldson D; Gray R; Northover JM; Stenning SP; Taylor I;
    Br J Surg; 2003 Oct; 90(10):1200-12. PubMed ID: 14515287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
    Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
    Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between blood transfusion and survival in a randomised multicentre trial of perioperative adjuvant portal chemotherapy in patients with colorectal cancer. The Swiss Group for Clinical Cancer Research (SAKK).
    Eur J Surg; 1997 Sep; 163(9):693-701. PubMed ID: 9311477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Portal vein chemotherapy for colorectal cancer: a meta-analysis of 4000 patients in 10 studies. Liver Infusion Meta-analysis Group.
    J Natl Cancer Inst; 1997 Apr; 89(7):497-505. PubMed ID: 9086006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. The Colorectal Cancer Chemotherapy Study Group of Japan.
    Jpn J Clin Oncol; 1995 Jun; 25(3):91-103. PubMed ID: 7596054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant perioperative portal vein or peripheral intravenous chemotherapy for potentially curative colorectal cancer: long-term results of a randomized controlled trial.
    Laffer U; Metzger U; Aeberhard P; Lorenz M; Harder F; Maibach R; Zuber M; Herrmann R
    Int J Colorectal Dis; 2008 Dec; 23(12):1233-41. PubMed ID: 18688620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial.
    Kerr DJ; McArdle CS; Ledermann J; Taylor I; Sherlock DJ; Schlag PM; Buckels J; Mayer D; Cain D; Stephens RJ; ;
    Lancet; 2003 Feb; 361(9355):368-73. PubMed ID: 12573372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant portal liver infusion in colorectal cancer with 5-fluorouracil/heparin versus urokinase versus control. Results of a prospective randomized clinical trial (colorectal adenocarcinoma trial I).
    Wereldsma JC; Bruggink ED; Meijer WS; Roukema JA; van Putten WL
    Cancer; 1990 Feb; 65(3):425-32. PubMed ID: 2404556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma.
    Lorenz M; Müller HH
    J Clin Oncol; 2000 Jan; 18(2):243-54. PubMed ID: 10637236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results of single course of adjuvant intraportal chemotherapy for colorectal cancer. Swiss Group for Clinical Cancer Research (SAKK).
    Lancet; 1995 Feb; 345(8946):349-53. PubMed ID: 7845115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
    Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
    Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of fluorouracil with additional levamisole, higher-dose folinic acid, or both, as adjuvant chemotherapy for colorectal cancer: a randomised trial. QUASAR Collaborative Group.
    Lancet; 2000 May; 355(9215):1588-96. PubMed ID: 10821362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative hepatic and regional arterial chemotherapy in the prevention of liver metastasis after colorectal cancer surgery.
    Xu J; Zhong Y; Weixin N; Xinyu Q; Yanhan L; Li R; Jianhua W; Zhiping Y; Jiemin C
    Ann Surg; 2007 Apr; 245(4):583-90. PubMed ID: 17414607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of portal vein chemotherapy on liver metastasis after surgical resection of colorectal cancer.
    Yu DS; Li Y; Huang XE; Lu YY; Wu XY; Liu J; Cao J; Xu X; Xiang J; Wang GP
    Asian Pac J Cancer Prev; 2012; 13(9):4699-701. PubMed ID: 23167405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.
    Hong YS; Nam BH; Kim KP; Kim JE; Park SJ; Park YS; Park JO; Kim SY; Kim TY; Kim JH; Ahn JB; Lim SB; Yu CS; Kim JC; Yun SH; Kim JH; Park JH; Park HC; Jung KH; Kim TW
    Lancet Oncol; 2014 Oct; 15(11):1245-53. PubMed ID: 25201358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised controlled trial of adjuvant chemotherapy by portal-vein perfusion after curative resection for colorectal adenocarcinoma.
    Fielding LP; Hittinger R; Grace RH; Fry JS
    Lancet; 1992 Aug; 340(8818):502-6. PubMed ID: 1354275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant regional chemotherapy after hepatic resection for colorectal metastases.
    Ambiru S; Miyazaki M; Ito H; Nakagawa K; Shimizu H; Nakajima N
    Br J Surg; 1999 Aug; 86(8):1025-31. PubMed ID: 10460638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematological toxicity of adjuvant portal liver infusion with fluorouracil, mitomycin and heparin.
    Weber W; Metzger U; Laffer U; Egeli R
    Anticancer Res; 1991; 11(1):365-8. PubMed ID: 1902076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.